ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX

Core Insights - ReShape Lifesciences has received an updated Medical Device License from Health Canada for its next generation Lap-Band® 2.0 FLEX and Tubing Kit, marking a significant milestone and growth catalyst for the company's Lap-Band® franchise [1][2] Product Details - The enhanced Lap-Band® 2.0 FLEX was designed based on physician feedback to improve patient experience, featuring adjustable band openings for optimizing eating habits and comfort [2] - The new Flex technology acts as a relief valve, allowing larger food pieces to pass through more easily, minimizing discomfort during swallowing [2] - Initial market release in the U.S. has received overwhelmingly positive feedback from surgeons, with data being analyzed to support the upcoming U.S. commercial launch [2] Company Overview - ReShape Lifesciences is a leading company in weight loss and metabolic health solutions, offering a range of products including the FDA-approved Lap-Band® System, which provides a minimally invasive treatment for obesity [3] - The company also has investigational products like the Diabetes Bloc-Stim Neuromodulation™ (DBSN™) system for type 2 diabetes and the non-surgical Obalon® balloon technology for weight loss [3]